FDA Clinical Investigator Disqualification List
Review available FDA clinical investigator disqualification records and source status. Distinguish disqualified, restricted and reinstated investigators.
Source availability
Available for screening
232 source records are available in the current dataset.
Records can overlap across lists; this is not a count of unique people or organizations.
- Latest successful check
- Our refresh schedule
- Every 24 hours
Data overview
FDA Clinical Investigator Disqualification Proceedings is published by United States Food and Drug Administration.
The available version contains 232 source records before any name search.
The entity-type breakdown is 232 people.
- Source records
- 232
- Publicly browsable records
- 232
- Entity types present
- 1
Record types and how to read these counts
Records by entity type
- People
- 232
- Other / unspecified
- 0
What these numbers mean
Counts describe this source’s current available records, before any name search. Records can overlap within and across lists. They are not counts of unique entities.
Publicly browsable records are the portion available in the public directory. A record’s presence does not by itself establish an active sanction.
Organizations include companies and other bodies. Other / unspecified means the source record has no more specific supported type.
What this source covers
The complete FDA table includes disqualified investigators, restricted agreements, reinstated investigators, removed restrictions and proceedings that did not result in disqualification. It is not an inspection-results database, a financial sanctions list or a list of people uniformly banned from clinical work.
Distinguish the action from its current effect
Compare the official FDA record ID and the current status. Totally Restricted is FDA’s historical wording for disqualification; Restricted means the investigator remains eligible subject to an agreement. Reinstated, restrictions-removed, not-disqualified and adequate-assurance records are retained as history and excluded from current restriction matching. Original proceedings and status dates remain distinct; no legal start or end date is invented.
- Read the stated action type and procedural status.
- Check the decision, dates and later amendments.
- Keep different orders about the same named party distinct.
FDA Clinical Investigator Disqualification Proceedings records
- Overlie, Paul A., MDFDA records a not-disqualified outcome for the clinical investigator Overlie, Paul A., MD on 12 Oct 2007. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Page, Roy C., MDFDA records disqualification of the clinical investigator Page, Roy C., MD on 4 Apr 2003.PersonClinical Investigators—Disqualification Proceedings
- Palazzo, Maria Carmen, MD, PhDFDA records disqualification of the clinical investigator Palazzo, Maria Carmen, MD, PhD on 1 Mar 2011.PersonClinical Investigators—Disqualification Proceedings
- Paulk, Jr., E Alan, MDFDA records disqualification of the clinical investigator Paulk, Jr., E Alan, MD on 8 Jan 1990.PersonClinical Investigators—Disqualification Proceedings
- Paull, Barry R., MDFDA records a totally restricted clinical-investigator outcome Paull, Barry R., MD on 12 Nov 1991.PersonClinical Investigators—Disqualification Proceedings
- Perez, George, MDFDA reports that the clinical-investigator restrictions were removed for Perez, George, MD on 18 Feb 2000. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Phillips, Christopher M.FDA records disqualification of the clinical investigator Phillips, Christopher M. on 11 Oct 2006.PersonClinical Investigators—Disqualification Proceedings
- Pierce, Keith Jeffrey, MDFDA records disqualification of the clinical investigator Pierce, Keith Jeffrey, MD on 24 Jun 2010.PersonClinical Investigators—Disqualification Proceedings
- Poisson, Roger C., MDFDA records disqualification of the clinical investigator Poisson, Roger C., MD on 28 May 1991.PersonClinical Investigators—Disqualification Proceedings
- Quarles, Carey L., PhDFDA records disqualification of the clinical investigator Quarles, Carey L., PhD on 29 Jul 2002.PersonClinical Investigators—Disqualification Proceedings
- Rackley, Charles E., MDFDA reports that the clinical-investigator restrictions were removed for Rackley, Charles E., MD on 17 Mar 1986. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Ramirez-Melendez, Ramon, MDFDA records disqualification of the clinical investigator Ramirez-Melendez, Ramon, MD on 21 Nov 2008.PersonClinical Investigators—Disqualification Proceedings
- Raper, Steven, MDFDA records restrictions on the clinical investigator Raper, Steven, MD on 10 Feb 2005.PersonClinical Investigators—Disqualification Proceedings
- Raval, Pramod, MDFDA records restrictions on the clinical investigator Raval, Pramod, MD on 25 Aug 2008.PersonClinical Investigators—Disqualification Proceedings
- Reagan, Luther M., PhDFDA records disqualification of the clinical investigator Reagan, Luther M., PhD on 8 Nov 1991.PersonClinical Investigators—Disqualification Proceedings
- Redd, Burton L., MDFDA records restrictions on the clinical investigator Redd, Burton L., MD on 8 Feb 2005.PersonClinical Investigators—Disqualification Proceedings
- Reuben, Scott S., MDFDA records disqualification of the clinical investigator Reuben, Scott S., MD on 5 Apr 2010.PersonClinical Investigators—Disqualification Proceedings
- Reynolds, Jr., James O., MDFDA reports that the clinical-investigator restrictions were removed for Reynolds, Jr., James O., MD on 9 Sep 1989. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Riba, Arthur, MDFDA reports that the clinical-investigator restrictions were removed for Riba, Arthur, MD on 29 Nov 2006. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Richards, Jon, MDFDA reports that the clinical-investigator restrictions were removed for Richards, Jon, MD on 12 May 2016. This source entry is excluded from current screening matches.PersonClinical Investigators—Disqualification Proceedings
- Ritter, Arnold, DOFDA records disqualification of the clinical investigator Ritter, Arnold, DO on 28 Feb 1980.PersonClinical Investigators—Disqualification Proceedings
- Roberts, Kathleen E., MDFDA records disqualification of the clinical investigator Roberts, Kathleen E., MD on 24 Nov 1964.PersonClinical Investigators—Disqualification Proceedings
- Roberts, William S., MDFDA records disqualification of the clinical investigator Roberts, William S., MD on 18 Jul 1991.PersonClinical Investigators—Disqualification Proceedings
- Robin, Bennett, MDFDA records disqualification of the clinical investigator Robin, Bennett, MD on 19 Jun 1964.PersonClinical Investigators—Disqualification Proceedings
- Rosenthal, C J., MDFDA records disqualification of the clinical investigator Rosenthal, C J., MD on 21 Jan 1998.PersonClinical Investigators—Disqualification Proceedings
- Rossner, Stephen D., MDFDA records disqualification of the clinical investigator Rossner, Stephen D., MD on 21 Feb 2008.PersonClinical Investigators—Disqualification Proceedings
- Roth, Stanley F., MDFDA records disqualification of the clinical investigator Roth, Stanley F., MD on 3 Aug 1982.PersonClinical Investigators—Disqualification Proceedings
- Rotstein, Jerome, MDFDA records disqualification of the clinical investigator Rotstein, Jerome, MD on 3 Dec 1975.PersonClinical Investigators—Disqualification Proceedings
- Rowan, Noel M., MDFDA records disqualification of the clinical investigator Rowan, Noel M., MD on 10 Jun 1985.PersonClinical Investigators—Disqualification Proceedings
- Rubin, Wallace, MDFDA records disqualification of the clinical investigator Rubin, Wallace, MD on 13 Mar 1970.PersonClinical Investigators—Disqualification Proceedings
Screen customers against the FDA Clinical Investigator Disqualification Proceedings
Start free250 free live screenings • One lifetime allowance • API + dashboard • No credit card
Questions about US FDA Clinical Investigator Disqualification Proceedings
Does an FDA investigator listing mean the person is disqualified?
No. Read FDA's stated status and the linked case documents. The database covers past and current proceedings. It includes people who were disqualified, people working under a restricted agreement, people later reinstated, and cases that did not lead to a ban. These outcomes are not the same. A restricted investigator may still receive investigational products if the agreement allows it. FDA's old phrase “totally restricted” means disqualified, rather than the less severe restricted status. “Restrictions removed” means the agreement's limits no longer apply. Check that the entry concerns the person you mean and that its status still applies. An old case alone does not prove a current ban. This database is separate from the FDA drug-product debarment list. Read the publisher’s FDA Clinical Investigator Disqualification Proceedings guidance.
Who publishes US FDA Clinical Investigator Disqualification Proceedings?
The catalog identifies US Food and Drug Administration as the publisher in United States. Open the publisher reference. SanctionsKit’s source profile is separate from that publisher’s original records and notices.
Can I select US FDA Clinical Investigator Disqualification Proceedings for screening?
The current source snapshot marks US FDA Clinical Investigator Disqualification Proceedings as available for screening. Select its source ID, us-fda-restricted, when your policy requires it. Check availability again when you run a request. This status does not by itself grant public browsing or export rights.
Can I browse current US FDA Clinical Investigator Disqualification Proceedings records here?
Current public records from US FDA Clinical Investigator Disqualification Proceedings can be browsed here. The current source contains 232 records. This counts source records, not distinct people, companies or assets. An empty name search is not a completed screening check.
May I reuse or export US FDA Clinical Investigator Disqualification Proceedings records?
Access to US FDA Clinical Investigator Disqualification Proceedings does not grant every right to copy, export or redistribute it. Read the source reuse terms and the attribution notice for the version you use. A public record page or working screening integration is not an export permission. Follow the conditions that apply to your intended use.
Continue exploring
Source discovery reference: OpenSanctions source catalog, captured . Import and record counts above come from SanctionsKit.